cbdMD, Inc. (YCBD): Rega marang bathi kanthi panyesuaian wutah

Simbol lan logo merek cbdMD, Inc. (YCBD)

The PEG ratio demonstrates the fundamental value of cbdMD, Inc. (YCBD) amid regulatory risks and pricing pressure within the CBD sector. 0.00 captures the current state of this parameter as the company implements ESG standards through eco-friendly packaging and sustainable farming. The asset is currently hitting a cyclical bottom, restructuring sales toward a direct-to-consumer online channel to combat declining demand.

YCBD - Pangali PEG cbdMD Inc. ing rentang 04.07.2022 - 10.11.2026
Produk seri cbdMD

To objectively evaluate cbdMD, Inc. (YCBD), it is necessary to compare the business's market value with its earnings growth, which is achieved via the PEG growth stock filter. This indicator determines the degree of the asset's undervaluation: a value below one signals growth potential, which is critically important for cbdMD, Inc. (YCBD) during its period of online distribution optimization and as it overcomes a cyclical downturn in demand for CBD products.

Perusahaan pesaing

HLN (Haleon PLC) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Kenvue Corp KVUE|Verona Pharma Inc. (VRNA) - Rega marang bathi kanthi panyesuaian wutah|MENS: Pangali rega marang bathi tumrap wutah|ligand.com - Rasio nilai perusahaan marang wutah bathi|AMRX: Pangali PEG|Perrigo Company PLC - Koefisien bali modal nimbang wutah|ALVO (Alvotech Corp) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Liquidia Inc. LQDA|Rasio rega marang bathi tumrap wutah Galapagos NV (GLPG)|ANIP (anipharmaceuticals.com) - Koefisien bali modal nimbang wutah|Pangali PEG MNKD (MannKind)|AMPH - Pangali rega marang bathi tumrap wutah|Pacira - Pangali PEG|SPRY: Rasio rega marang bathi tumrap wutah|TBPH: Pangali PEG|Rasio P/E diaturake wutah AQST|Rasio rega marang bathi tumrap wutah scPharmaceuticals, Inc.|Pangali rega marang bathi tumrap wutah Tectonic (TECX)|Pangali PEG TNXP|sxtchina.com - Rasio P/E diaturake wutah|Eupraxia Pharmaceuticals Inc. - Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah BHST|eXoZymes - Pangali PEG|Kapitalisasi marang bathi resik kanthi nimbang wutah Oramed Pharmaceuticals ORMP|enterabio.com (ENTX) - Rasio rega marang bathi tumrap wutah|Rasio P/E diaturake wutah HYFT|ABVC (ABVC BioPharma) - Pangali PEG|Pangali rega marang bathi tumrap wutah cumberlandpharma.com (CPIX)|Pangali rega marang bathi tumrap wutah QNTM (Quantum BioPharma)|Kapitalisasi marang bathi resik kanthi nimbang wutah FibroGen Inc|Telomir Pharma - Pangali rega marang bathi tumrap wutah|Rani Therapeutics Holdings (RANI) - Rega marang bathi kanthi panyesuaian wutah|Synergy CHC Corporation - Pangali PEG|Rallybio Corporation (RLYB) - Pangali rega marang bathi tumrap wutah|LEXX: Pangali PEG|PULM (Pulmatrix Inc) - Rasio rega marang bathi tumrap wutah|PTHL (Pheton Holdings Limited) - Pangali PEG|Rasio P/E diaturake wutah APM (Aptorum)|Rasio rega marang bathi tumrap wutah Lyra Therapeutics, Inc. (LYRA)|IBO: Rasio kapitalisasi marang bathi lan wutah|Pangali PEG TNFA (TNF Pharmaceuticals, Inc.)|Koefisien bali modal nimbang wutah PRFX|Auris Medical - Pangali PEG|LIPO - Pangali PEG|OptiNose, Inc. (OPTN) - Rasio rega marang bathi tumrap wutah|pieris.com - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Procaps|Pangali rega marang bathi tumrap wutah Petros Pharmaceuticals Inc (PTPI)|Pangali PEG QLI|Pangali PEG ACELYRIN Inc. (SLRN)|TFF Pharmaceuticals - Pangali rega marang bathi tumrap wutah